No Data
No Data
Is TG Therapeutics, Inc. (TGTX) Set to Explode in 2025?
The Analyst Verdict: TG Therapeutics In The Eyes Of 5 Experts
TD Cowen Initiates TG Therapeutics(TGTX.US) With Buy Rating, Announces Target Price $50
TG Therapeutics Initiated at Buy by TD Cowen
TG Therapeutics Price Target Announced at $50.00/Share by TD Cowen
Institutional Investors in TG Therapeutics, Inc. (NASDAQ:TGTX) See US$145m Decrease in Market Cap Last Week, Although Long-term Gains Have Benefitted Them.
No Data
No Data